Clinical Malignant Hematology Clinical Malignant Hematology

Clinical Malignant Hematology

Mikkael A. Sekeres and Others
    • $279.99
    • $279.99

Publisher Description

The only comprehensive guide to the clinical management of hematologic and lymphatic cancers

Filling an unmet need in the clinical literature, this commanding, just-in-time reference sheds light on the full spectrum of cancers in the blood, bone marrow, and lymphatic system (leukemia, lymphoma, myeloma). Clinical Malignant Hematology is edited by staff members from the renowned Taussig Cancer Center at the Cleveland Clinic, which has pioneered some of the most important clinical discoveries and treatment trends in recent years.

Look inside and you'll see a consistent, unified patient management strategy in each chapter, as well as a streamlined three-section format that expertly examines ontogeny and physiology of blood cells, myeloid neoplasia, and lymphoid neoplasia. You'll also find never-before-published perspectives and precise recommendations for dosing and other critical areas that reflect the latest scholarship of this increasingly vital field.

Features

Full coverage of all treatment modalities-chemotherapy, monoclonal antibodies, and hematopoietic stem cell transplantation

Strong background chapters that offer guidance on how to address treatment complications and other supportive care issues

A detailed, regimen-based orientation in each chapter

Abundance of clinical pictures and photomicrographs displaying examples of peripheral blood smears and bone marrow aspirates

Uniform headings and tables in each chapter, which convey specific recommendations on the work-up, staging, diagnosis, differential diagnosis, and treatment of hematologic malignancies

Nearly 200 illustrations

GENRE
Professional & Technical
RELEASED
2007
April 13
LANGUAGE
EN
English
LENGTH
1,024
Pages
PUBLISHER
McGraw Hill LLC
SELLER
The McGraw-Hill Companies, Inc.
SIZE
49.5
MB

More Books by Mikkael A. Sekeres, Matt Kalacyio & Brian Bolwell

When Blood Breaks Down When Blood Breaks Down
2020
Drugs and the FDA Drugs and the FDA
2022
Textbook of Uncommon Cancer Textbook of Uncommon Cancer
2017